Alfonso G. Zulueta's most recent trade in CTS Corp. was a trade of 2,400 Common Stock done . Disclosure was reported to the exchange on Nov. 7, 2024.
Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
---|---|---|---|---|---|---|---|---|---|---|
CTS Corp. | Alfonso G. Zulueta | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 Nov 2024 | 2,400 | 32,413 (0%) | 0% | 0 | Common Stock | |
CTS Corp. | Alfonso G. Zulueta | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Nov 2023 | 3,600 | 30,013 (0%) | 0% | 0 | Common Stock | |
Syneos Health Inc - Ordina... | Alfonso G. Zulueta | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 May 2023 | 4,863 | 8,356 (0%) | 0% | 0 | Class A Common Stock | |
CTS Corp. | Alfonso G. Zulueta | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Nov 2022 | 3,100 | 26,413 (0%) | 0% | 0 | Common Stock | |
Syneos Health Inc - Ordina... | Alfonso G. Zulueta | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 May 2022 | 2,839 | 3,493 (0%) | 0% | 0 | Class A Common Stock | |
Syneos Health Inc - Ordina... | Alfonso G. Zulueta | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 Jan 2022 | 654 | 654 (0%) | 0% | 0 | Class A Common Stock | |
CTS Corp. | Alfonso G. Zulueta | Director | Grant, award, or other acquisition of securities at price $ 36.69 per share. | 04 Nov 2021 | 3,600 | 23,313 (0%) | 0% | 36.7 | 132,084 | Common Stock |
Eli Lilly | Alfonso G. Zulueta | SVP & President, Lilly Intl | Grant, award, or other acquisition of securities at price $ 205.77 per share. | 08 Feb 2021 | 29,037 | 56,947 (0%) | 0% | 205.8 | 5,974,943 | Common Stock |
Eli Lilly | Alfonso G. Zulueta | SVP & President, Lilly Intl | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Feb 2021 | 10,706 | 10,706 | - | - | Restricted Stock Unit | |
Eli Lilly | Alfonso G. Zulueta | SVP & President, Lilly Intl | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Feb 2021 | 16,754 | 0 | - | - | Restricted Stock Unit | |
Eli Lilly | Alfonso G. Zulueta | SVP & President, Lilly Intl | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Feb 2021 | 16,754 | 35,400 (0%) | 0% | 0 | Common Stock | |
Eli Lilly | Alfonso G. Zulueta | SVP & President, Lilly Intl | Payment of exercise price or tax liability using portion of securities received from the company at price $ 207.97 per share. | 01 Feb 2021 | 7,490 | 27,910 (0%) | 0% | 208.0 | 1,557,695 | Common Stock |
CTS Corp. | Alfonso G. Zulueta | Director | Grant, award, or other acquisition of securities at price $ 29.23 per share. | 05 Nov 2020 | 4,200 | 19,713 (0%) | 0% | 29.2 | 122,766 | Common |